Inappropriate Antidiuretic Hormone Syndrome
📧 Sign up to get email alerts when something new happens for Inappropriate Antidiuretic Hormone Syndrome.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-20EMA Authorised: Samsca (tolvaptan) — Otsuka Pharmaceutical Netherlands B.V.
Tolvaptan (Samsca) has been authorised by the EMA for the treatment of Inappropriate Antidiuretic Hormone Syndrome (SIADH).